Amgen/ US0311621009 /
9/13/2024 9:59:59 PM | Chg. +2.43 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
332.42USD | +0.74% | 55,300 Turnover: 18.34 mill. |
-Bid Size: - | -Ask Size: - | 178.64 bill.USD | 2.60% | 26.47 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 12.56 USD | 3.12% |
EPS Diluted: | 12.49 USD | 3.14% |
Revenues per Share: | 52.60 USD | 6.70% |
Book Value per Share: | 11.63 USD | 69.61% |
Cash Flow per Share: | 15.81 USD | -13.17% |
Dividend per Share: | 8.64 USD | 8.68% |
Total | in mill. | |
Revenues: | 28,190.00 USD | 7.09% |
Net Income: | 6,717.00 USD | 2.52% |
Operating Cash Flow: | 8,471.00 USD | - |
Cash and Cash Equivalents: | 10,944.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 26.47 | 22.93 |
P/S Ratio: | 6.32 | 5.48 |
P/BV ratio: | 28.59 | 24.77 |
P/CF Ratio: | 21.03 | 18.22 |
PEG: | 8.48 | 7.35 |
Earnings Yield: | 3.78% | 4.36% |
Dividend Yield: | 2.60% | 3.00% |
Market Capitalization | ||
Market Capitalization: | 178.64 bill. USD | 154.36 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 537.33 mill. |
Profitability
Gross Profit Margin: | 70.02% |
EBIT Margin: | 28.01% |
Net Profit Margin: | 23.83% |
Return on Equity: | 107.78% |
Return on Assets: | 6.91% |
Financial Strength
Liquidity I / Cash Ratio: | 0.60% |
Liquidity II / Quick Ratio: | 0.99% |
Liquidity III / Current Ratio: | 1.65% |
Debt / Equity Ratio: | 10.37% |
Dynam. Debt / Equity Ratio: | 1,073.33% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |